NCT06533670View on ClinicalTrials.gov

TME Alteration in HER2 Positive Breast Cancer

RecruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

July 19, 2024

Primary Completion Date

July 19, 2026

Study Completion Date

July 19, 2026

Conditions

Breast CancerHER2-positive Breast CancerChemotherapy Effect

Trial Locations (1)

Unknown

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors

lead

Seoul National University Hospital

OTHER